Our featured article for February is a Review by Linda Douw and colleagues on multiscale network perspectives on glioma - read it for free here: https://t.co/qM6Bv0ro4F
🚨New review on multiscale network perspectives on glioma is out in @NatRevNeurol!
🧠We delineate how tumour biology networks interact with the connectome and symptoms, and how we can work towards 'network-informed care': https://t.co/fw97XrodZ8
Excited this is out in @NatRevNeurol! New review exploring how networks along different axes (tumor biology, connectome, and symptoms) interact to help explain the clinical presentation of glioma. Thanks to authors @LindaDouw and Jaap Reijneveld! @harvardneuromds@MGHNeurology
1/ Excited to share our new study, product of a 6-year collaborative effort by @michelle_monje lab and @VenkteshLab
illustrating that neuronal activity regulates the progression of small cell lung cancer #SCLC in the lung and brain #CancerNeuroscience 🧵…
https://t.co/t0SN44MTBf
Presented at #AANAM:
In the HERCULES phase 3 trial involving participants with nonrelapsing secondary progressive multiple sclerosis, treatment with tolebrutinib resulted in a lower risk of disability progression than placebo. Full trial results: https://t.co/yD11WtGvZJ
@AANmember
The vaccine against Shingles helps protect against dementia, results of a natural experiment, adding to prior evidence
"implications are profound"
New @Nature
https://t.co/NmazPQdos2
https://t.co/HnBsMQYWfT
‼️PhD Position now available in my lab‼️
Do you like:
* Neurodegenerative disease?
* Neuroimaging and/or multi-omics?
* AI and data-driven life science?
Want to work with @RikOssenkoppele Alexandra Young and Laura Wisse?
Apply here: https://t.co/aQ3g5pZWJe
Please rt/share 🙏
Super excited to share that I have matched @harvardneuromds for neurology residency!! Looking forward to rigorous yet rewarding clinical training, continuing research in cancer neuroscience, and learning from incredible medical educators at @MGHNeurology and @BWHNeurology!!
🎉Exciting news! Our latest work on Glioma-Innervating Neurons has just been published in PNAS!🔗 Read the full article here: https://t.co/wwNgoY5Ewd
A huge thank you to my co-mentors @blsabatini, @HaigisLab and co-authors. @MGHNeuroOnc @MGHCancerCenter @MGHNeurology
Learned so much writing this review on the approach to Altered Mental Status with @Orilieberman@neurores_ucsf for Seminars in Neurology! Thank you to @caseyalbin for inviting us! @DxRxEdu @rabihmgeha @NMatch2025 🧠♥️
https://t.co/bLWZhB3v0a
How are genetic risk for mental illness, personalized functional brain networks, and overall psychopathology related during early adolescence? New preprint out now https://t.co/pc11gYp9ge and I'll be presenting a poster at #Flux2024 this Sunday! (1/17)
A new @JAMA_current study found a blood test had high diagnostic accuracy for identifying Alzheimer disease among adults with cognitive symptoms.
This test could lead to early diagnosis and may facilitate timely access to new treatments.
#AAIC24
https://t.co/FFwOm2jNrl
2 new large observational studies show GLP-1 drugs are associated with reduced dementia in people with diabetes
—Sweden, vs other drugs for diabetes (Figure)
https://t.co/8U2urhxP0U
—US Medicare population, vs DPP-4
https://t.co/4TXvIHsdNz
Most patients with sepsis don't need anti-anaerobic antibiotics. But most get them anyway. Why not, what's the harm?
I worry the harm is considerable.
Our new study in @JAMAInternalMed: using a 15-month pip-tazo shortage to answer this question.
1/n
https://t.co/1nOhsUaio0
‼️We’re hiring! @CHOP_Research Seeking imaging/informatics folks and/or those passionate about human development/disease & imaging-genetics! Massive data sandbox (N>200k)! Highly collaborative & welcoming environment! DM/email or see us @OHBM@Aaron_A_B
https://t.co/kmOLT2ldJO